The association linking corticosteroid therapy with the development of posterior subcapsular
cataracts has been well documented. These drugs are widely used therapeutically …

Prolonged use of glucocorticoids is a significant risk factor for the development of posterior
subcapsular cataract. This places restrictions on the use of glucocorticoids in the treatment …

• While the cataractogenic effects of corticosteroids are beyond dispute, disagreement exists
concerning effects of total dose, intensity of dose, and duration of administration on cataract …

Background The use of systemic corticosteroids is a risk factor for the development of
posterior subcapsular cataracts, but the association between inhaled corticosteroids and …

Steroid-induced posterior subcapsular cataracts (PSCs) exhibit three main distinctive
characteristics:(i) association only with steroids possessing glucocorticoid activity,(ii) …

A group of 56 patients who had received sustained, systemic corticosteroid therapy were
examined in order to determine the incidence of posterior subcapsular cataracts. Thirty-eight …

OBJECTIVE:: Longitudinal associations between inhaled and oral corticosteroid use and 10-
year incident cataract were examined. DESIGN: Population-based cohort study …

POSTERIOR subcapsular cataracts (PSC) are generally associated with exposure to toxic
agents, posterior intraocular disease, ionizing radiation, or blunt trauma. As a rule these …

Topical ophthalmic, oral, and intravenous corticosteroids have long been associated with
ocular side effects. Recent data suggest that inhaled corticosteroids are also associated with …

A frequent manifestation of long-term glucocorticoid administration is the occurrence of
posterior subcapsular cataracts. The molecular basis for this effect has not yet been …